MEI Pharma Inc.

NASDAQ: MEIP · Real-Time Price · USD
4.89
-0.01 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
4.98
1.90%
After-hours: Aug 15, 2025, 07:55 PM EDT

MEI Pharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
17.78M -31.84M -54.45M -50.58M
Depreciation & Amortization
383K 386K 326K 285K
Stock-Based Compensation
2.28M 3.59M 8.35M 10.24M
Other Working Capital
-81.21M -23.16M 15.31M 22.29M
Other Non-Cash Items
13.36M 1.43M -19.84M -18.12M
Deferred Income Tax
n/a -1.1M n/a n/a
Change in Working Capital
-84.28M -24.95M 16.88M 26.2M
Operating Cash Flow
-50.47M -52.48M -48.75M -31.96M
Capital Expenditures
-7K -35K -479K -708K
Cash Acquisitions
n/a -53.73M -7.37M -25.42M
Purchase of Investments
-58.23M -101.76M -272.65M -420.15M
Sales Maturities Of Investments
107.38M 155.49M 280.02M 445.57M
Other Investing Acitivies
n/a 53.73M 7.37M 25.42M
Investing Cash Flow
49.14M 53.69M 6.89M 24.71M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -40K n/a n/a
Dividend Paid
-11.66M n/a n/a n/a
Other Financial Acitivies
-208K -40K -3.27M 268K
Financial Cash Flow
-11.87M -40K 49.05M 3.47M
Net Cash Flow
-13.2M 1.17M 7.2M -3.79M
Free Cash Flow
-50.48M -52.52M -49.23M -32.67M